vs

Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and SOUNDTHINKING, INC. (SSTI). Click either name above to swap in a different company.

SOUNDTHINKING, INC. is the larger business by last-quarter revenue ($24.8M vs $20.0M, roughly 1.2× AGIOS PHARMACEUTICALS, INC.). SOUNDTHINKING, INC. runs the higher net margin — -11.2% vs -541.1%, a 529.9% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs 5.9%). SOUNDTHINKING, INC. produced more free cash flow last quarter ($3.7M vs $-97.3M). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs -1.2%).

Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.

SoundThinking, Inc. is a public safety technology provider specializing in acoustic monitoring solutions, most notably gunshot detection systems. It delivers data-driven tools and analytics services to law enforcement agencies, municipal governments and public safety organizations primarily across North America, helping improve emergency response efficiency and community safety outcomes.

AGIO vs SSTI — Head-to-Head

Bigger by revenue
SSTI
SSTI
1.2× larger
SSTI
$24.8M
$20.0M
AGIO
Growing faster (revenue YoY)
AGIO
AGIO
+80.2% gap
AGIO
86.1%
5.9%
SSTI
Higher net margin
SSTI
SSTI
529.9% more per $
SSTI
-11.2%
-541.1%
AGIO
More free cash flow
SSTI
SSTI
$101.0M more FCF
SSTI
$3.7M
$-97.3M
AGIO
Faster 2-yr revenue CAGR
AGIO
AGIO
Annualised
AGIO
56.1%
-1.2%
SSTI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AGIO
AGIO
SSTI
SSTI
Revenue
$20.0M
$24.8M
Net Profit
$-108.0M
$-2.8M
Gross Margin
90.6%
50.9%
Operating Margin
-608.9%
-10.2%
Net Margin
-541.1%
-11.2%
Revenue YoY
86.1%
5.9%
Net Profit YoY
-11.9%
32.0%
EPS (diluted)
$-1.86
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGIO
AGIO
SSTI
SSTI
Q4 25
$20.0M
$24.8M
Q3 25
$12.9M
$25.1M
Q2 25
$12.5M
$25.9M
Q1 25
$8.7M
$28.3M
Q4 24
$10.7M
$23.4M
Q3 24
$9.0M
$26.3M
Q2 24
$8.6M
$27.0M
Q1 24
$8.2M
$25.4M
Net Profit
AGIO
AGIO
SSTI
SSTI
Q4 25
$-108.0M
$-2.8M
Q3 25
$-103.4M
$-2.0M
Q2 25
$-112.0M
$-3.1M
Q1 25
$-89.3M
$-1.5M
Q4 24
$-96.5M
$-4.1M
Q3 24
$947.9M
$-1.4M
Q2 24
$-96.1M
$-752.0K
Q1 24
$-81.5M
$-2.9M
Gross Margin
AGIO
AGIO
SSTI
SSTI
Q4 25
90.6%
50.9%
Q3 25
87.0%
54.3%
Q2 25
86.3%
53.3%
Q1 25
87.6%
58.5%
Q4 24
88.3%
50.0%
Q3 24
91.3%
58.0%
Q2 24
82.6%
59.6%
Q1 24
92.3%
58.6%
Operating Margin
AGIO
AGIO
SSTI
SSTI
Q4 25
-608.9%
-10.2%
Q3 25
-907.4%
-8.2%
Q2 25
-1020.1%
-11.4%
Q1 25
-1222.0%
-4.2%
Q4 24
-1165.3%
-17.7%
Q3 24
-1146.9%
-4.0%
Q2 24
-1228.3%
-0.2%
Q1 24
-1124.3%
-10.3%
Net Margin
AGIO
AGIO
SSTI
SSTI
Q4 25
-541.1%
-11.2%
Q3 25
-803.1%
-8.1%
Q2 25
-899.4%
-12.1%
Q1 25
-1023.3%
-5.2%
Q4 24
-899.6%
-17.4%
Q3 24
10574.7%
-5.5%
Q2 24
-1115.7%
-2.8%
Q1 24
-995.8%
-11.4%
EPS (diluted)
AGIO
AGIO
SSTI
SSTI
Q4 25
$-1.86
$-0.22
Q3 25
$-1.78
$-0.16
Q2 25
$-1.93
$-0.24
Q1 25
$-1.55
$-0.12
Q4 24
$-1.44
$-0.32
Q3 24
$16.22
$-0.11
Q2 24
$-1.69
$-0.06
Q1 24
$-1.45
$-0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGIO
AGIO
SSTI
SSTI
Cash + ST InvestmentsLiquidity on hand
$89.1M
$15.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.2B
$72.2M
Total Assets
$1.3B
$135.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGIO
AGIO
SSTI
SSTI
Q4 25
$89.1M
$15.8M
Q3 25
$92.7M
$11.8M
Q2 25
$80.9M
$8.9M
Q1 25
$79.0M
$11.7M
Q4 24
$76.2M
$13.2M
Q3 24
$253.7M
$15.3M
Q2 24
$84.5M
$9.8M
Q1 24
$118.8M
$8.5M
Stockholders' Equity
AGIO
AGIO
SSTI
SSTI
Q4 25
$1.2B
$72.2M
Q3 25
$1.3B
$73.5M
Q2 25
$1.4B
$74.5M
Q1 25
$1.5B
$73.8M
Q4 24
$1.5B
$72.4M
Q3 24
$1.6B
$73.3M
Q2 24
$660.5M
$75.6M
Q1 24
$743.9M
$74.8M
Total Assets
AGIO
AGIO
SSTI
SSTI
Q4 25
$1.3B
$135.8M
Q3 25
$1.4B
$134.4M
Q2 25
$1.5B
$134.8M
Q1 25
$1.6B
$136.3M
Q4 24
$1.7B
$136.8M
Q3 24
$1.8B
$141.7M
Q2 24
$773.1M
$145.9M
Q1 24
$849.7M
$145.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGIO
AGIO
SSTI
SSTI
Operating Cash FlowLast quarter
$-96.2M
$4.5M
Free Cash FlowOCF − Capex
$-97.3M
$3.7M
FCF MarginFCF / Revenue
-487.5%
14.9%
Capex IntensityCapex / Revenue
5.6%
3.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-377.3M
$4.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGIO
AGIO
SSTI
SSTI
Q4 25
$-96.2M
$4.5M
Q3 25
$-88.2M
$6.2M
Q2 25
$-77.1M
$-1.3M
Q1 25
$-111.5M
$-141.0K
Q4 24
$-133.2M
$-859.0K
Q3 24
$-84.2M
$13.7M
Q2 24
$-72.6M
$4.4M
Q1 24
$-99.9M
$5.0M
Free Cash Flow
AGIO
AGIO
SSTI
SSTI
Q4 25
$-97.3M
$3.7M
Q3 25
$-89.7M
$4.9M
Q2 25
$-78.0M
$-2.7M
Q1 25
$-112.3M
$-1.0M
Q4 24
$-134.1M
$-2.2M
Q3 24
$-84.6M
$12.4M
Q2 24
$-72.7M
$2.8M
Q1 24
$-100.0M
$2.8M
FCF Margin
AGIO
AGIO
SSTI
SSTI
Q4 25
-487.5%
14.9%
Q3 25
-696.5%
19.4%
Q2 25
-626.2%
-10.3%
Q1 25
-1286.4%
-3.7%
Q4 24
-1250.1%
-9.5%
Q3 24
-944.2%
47.4%
Q2 24
-844.4%
10.5%
Q1 24
-1221.2%
11.2%
Capex Intensity
AGIO
AGIO
SSTI
SSTI
Q4 25
5.6%
3.2%
Q3 25
12.1%
5.5%
Q2 25
7.0%
5.3%
Q1 25
8.8%
3.2%
Q4 24
9.0%
5.8%
Q3 24
4.7%
4.7%
Q2 24
1.8%
5.9%
Q1 24
1.7%
8.4%
Cash Conversion
AGIO
AGIO
SSTI
SSTI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-0.09×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons